They also showed how co-culture with HUVEC endothelial cells caused a heterogeneous response to RET inhibitors by activating bypass survival signals of EGFR, opening up a new frontier about the role of the tumor microenvironment in RET-TKIs’ resistance. The gene discussed is RET; the disease is neoplasm.